[HTML][HTML] Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence

B Russell, C Moss, G George, A Santaolalla… - …, 2020 - ncbi.nlm.nih.gov
Background Cancer and transplant patients with COVID-19 have a higher risk of developing
severe and even fatal respiratory diseases, especially as they may be treated with immune …

Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury

KE Swenson, ER Swenson - Critical care clinics, 2021 - criticalcare.theclinics.com
Acute respiratory distress syndrome (ARDS) is a complex syndrome of acute lung injury
leading to noncardiogenic pulmonary edema from many causes that is heterogenous in its …

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

X Li, S Xu, M Yu, K Wang, Y Tao, Y Zhou, J Shi… - Journal of Allergy and …, 2020 - Elsevier
Background In December 2019, the coronavirus disease 2019 (COVID-19) outbreak
occurred in Wuhan. Data on the clinical characteristics and outcomes of patients with severe …

The landscape of cognitive function in recovered COVID-19 patients

H Zhou, S Lu, J Chen, N Wei, D Wang, H Lyu… - Journal of psychiatric …, 2020 - Elsevier
This study aims to evaluate the impacts of COVID-19 on cognitive functions in recovered
patients and its relationship with inflammatory profiles. Twenty-nine patients recovered from …

[HTML][HTML] Could SARS-CoV-2-induced hyperinflammation magnify the severity of coronavirus disease (CoViD-19) leading to acute respiratory distress syndrome?

ASS Girija, EM Shankar, M Larsson - Frontiers in immunology, 2020 - frontiersin.org
The exaggerated immune response induced in the lower respiratory tract against
coronaviruses (CoVs), including CoViD-19 (2019-nCoV), appears to contribute to the …

[PDF][PDF] Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury

Y Liu, C Zhang, F Huang, Y Yang, F Wang… - National Science …, 2020 - academic.oup.com
A recent outbreak of pneumonia in Wuhan, China was found to be caused by a 2019 novel
coronavirus (2019-nCoV or SARS-CoV-2 or HCoV-19). We previously reported the clinical …

[HTML][HTML] Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China

Z Zeng, H Yu, H Chen, W Qi, L Chen, G Chen, W Yan… - Critical Care, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is a newly emerging infectious
disease and rapidly escalating epidemic caused by the severe acute respiratory syndrome …

[HTML][HTML] Psycho-neuroendocrine-immune interactions in COVID-19: potential impacts on mental health

Í Raony, CS de Figueiredo, P Pandolfo… - Frontiers in …, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2). The impacts of the disease may be beyond the …

[HTML][HTML] Update advances on C-reactive protein in COVID-19 and other viral infections

Y Luan, C Yin, Y Yao - Frontiers in Immunology, 2021 - frontiersin.org
Severe coronavirus disease 2019 (COVID-19) can manifest as a viral-induced
hyperinflammation with multiorgan dysfunction. It has been documented that severe COVID …

[HTML][HTML] The role of IL-6 in coronavirus, especially in COVID-19

X Wang, G Tang, Y Liu, L Zhang, B Chen… - Frontiers in …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects both people and
animals and may cause significant respiratory problems, including lung illness: Corona …